Standing orders for influenza and pneumococcal polysaccharide vaccination: Correlates identified in a national survey of U.S. Primary care physicians
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2296
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Standing orders for influenza and pneumococcal polysaccharide vaccination: Correlates identified in a national survey of U.S. Primary care physicians ; volume:13 ; number:1 ; day:20 ; month:3 ; year:2012 ; pages:1-10 ; date:12.2012
BMC family practice ; 13, Heft 1 (20.3.2012), 1-10, 12.2012
- Creator
-
Albert, Steven M.
- Contributor
-
Nowalk, Mary Patricia
Yonas, Michael A.
Zimmerman, Richard K.
Ahmed, Faruque
SpringerLink (Online service)
- DOI
-
10.1186/1471-2296-13-22
- URN
-
urn:nbn:de:1111-2016021812588
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Albert, Steven M.
- Nowalk, Mary Patricia
- Yonas, Michael A.
- Zimmerman, Richard K.
- Ahmed, Faruque
- SpringerLink (Online service)
Other Objects (12)
General Circulars & Standing Orders
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Standing orders : Handlungsanweisungen für Feuerwehr-Erste-Hilfe-Teams
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
The effect of age on the response to the pneumococcal polysaccharide vaccine
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
AA16, a new lytic polysaccharide monooxygenase family identified in fungal secretomes
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis
General Circulars & Standing Orders
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Standing orders : Handlungsanweisungen für Feuerwehr-Erste-Hilfe-Teams
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
The effect of age on the response to the pneumococcal polysaccharide vaccine
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
AA16, a new lytic polysaccharide monooxygenase family identified in fungal secretomes
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
Mortality reduction with 23-valent pneumococcal polysaccharide vaccine: a systematic review and meta-analysis
General Circulars & Standing Orders
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Standing orders : Handlungsanweisungen für Feuerwehr-Erste-Hilfe-Teams
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
The effect of age on the response to the pneumococcal polysaccharide vaccine
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
AA16, a new lytic polysaccharide monooxygenase family identified in fungal secretomes
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study